J. Richard Miller

5.3k citations

35 papers · 1.6k indexed · h-index 22

Biochemistry top 1%
- Biochemical Acid Research Studies 4
- Amino Acid Enzymes and Metabolism 3
Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 3
Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders 4
Molecular Biology top 10%
- Biochemical and Molecular Research 6
- Cancer therapeutics and mechanisms 4
Organic Chemistry top 10%
Cell Biology
- Biotin and Related Studies 3
Materials Chemistry
- Enzyme Structure and Function 2

Co-authors: Dale E. Edmondson John E. Cronan Michael A. MarlettaXin ZhaoA.G. Evdokimov Yanfang Jiang Grover L. Waldrop Gary W. Ashley
Cited by: Biochemistry Molecular Medicine Clinical Biochemistry
Partner nations: United States United Kingdom Poland

In The Last Decade

J. Richard Miller

35 papers receiving 1.5k citations

Peers

Countries citing papers authored by J. Richard Miller

Since Specialization

Citations

This map shows the geographic impact of J. Richard Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Richard Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Richard Miller more than expected).

Fields of papers citing papers by J. Richard Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Richard Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Richard Miller. The network helps show where J. Richard Miller may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. Richard Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Richard Miller Line = papers co-authored together J. Richard Miller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Risk Evaluation of N-Nitrosamines in Drug-Linker Intermediates Used To Generate Antibody–Drug Conjugates Osama Chahrour,Paul G. Bulger,Olivier Dirat,Kate Schrier,Andrew T. Parsons,J. Gair Ford,Frank Bernardoni,Evan M. Hetrick,Llorente Boñaga,Kevin P. Cole,J. Richard Miller,Qunying Zhang,Michael T. Jones	2024	2
2	Risk Assessment and Control of N-Nitrosamines in Antibody–Drug Conjugates: Current Industry Practices Paul G. Bulger,Michael T. Jones,J. Gair Ford,Kate Schrier,Kevin P. Cole,Frank Bernardoni,Olivier Dirat,Qunying Zhang,Osama Chahrour,J. Richard Miller,Llorente Boñaga,Andrew T. Parsons,Lan Yang	2024	2
3	Discovery of non-boronic acid Arginase 1 inhibitors through virtual screening and biophysical methods Symon Gathiaka,R.L. Palte,Sung‐Sau So,Xiaomei Chai,J. Richard Miller,Reshma Kuvelkar,Xiujuan Wen,Steven Cifelli,Anthony Kreamer,Andy Liaw,David G. McLaren,Christian Fischer	2023	2
4	Identification of Potent Reverse Indazole Inhibitors for HPK1 Elsie C. Yu,Joey L. Methot,Xavier Fradera,Charles A. Lesburg,Brian M. Lacey,Phieng Siliphaivanh,Ping Liu,Dustin Smith,Zangwei Xu,Jennifer Piesvaux,Shuhei Kawamura,Haiyan Xu,J. Richard Miller,Mark Bittinger,Alexander Pasternak	2021	24
5	Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds Brandon Vara,Samuel M. Levi,Abdelghani Achab,David A. Candito,Xavier Fradera,Charles A. Lesburg,Shuhei Kawamura,Brian M. Lacey,Jongwon Lim,Joey L. Methot,Zangwei Xu,Haiyan Xu,Dustin Smith,Jennifer Piesvaux,J. Richard Miller,Mark Bittinger,Sheila Ranganath,David Jonathan Bennett,Erin F. DiMauro,Alexander Pasternak	2021	31
6	Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold Wensheng Yu,Yongqi Deng,David L. Sloman,Derun Li,Kun Liu,Xavier Fradera,Charles A. Lesburg,Theodore A. Martinot,Amy C. Doty,Heidi M. Ferguson,J. Richard Miller,Ian Knemeyer,Karin M. Otte,Stella Vincent,Nunzio Sciammetta,David Jonathan Bennett,Yongxin Han	2021	6
7	Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma Handan Xiang,Carlo P. Ramil,Josephine Hai,Chunsheng Zhang,Huijun Wang,Amanda A. Watkins,Roshi Afshar,Peter Georgiev,Marc A. Sze,Xuelei S. Song,Patrick J. Curran,Mangeng Cheng,J. Richard Miller,Dongyu Sun,Andrey Loboda,Yanlin Jia,Lily Y. Moy,An Chi,Philip E. Brandish	2020	190
8	Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice Amy G. Aslamkhan,Qiuwei Xu,Amy F Loughlin,Heather Vu,Stephen Pacchione,Bhavana Bhatt,Ivy Garfinkel,Tara Grady Styring,Lisa LaFranco-Scheuch,Kara Pearson,Spencer Reynolds,Nianyu Li,Heather Zhou,J. Richard Miller,Nicolas Solban,Alan Bass,Warren E. Glaab	2020	6
9	Mg2+ regulation of kinase signaling and immune function Chryssa Kanellopoulou,Alex George,Evan Masutani,Jennifer L. Cannons,Juan C. Ravell,Tori N. Yamamoto,Margery Smelkinson,Ping Jiang,Mami Matsuda‐Lennikov,Julie Reilley,Robin Handon,Ping‐Hsien Lee,J. Richard Miller,Nicholas P. Restifo,Lixin Zheng,Pamela L. Schwartzberg,Matthew A. Young,Michael J. Lenardo	2019	57
10	Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma William T. Phillips,Beth Goins,Ande Bao,D. Vargas,J. E. Guttierez,A. Trevino,J. Richard Miller,Jack Henry,R. Zuniga,Giacomo G. Vecil,A. J. Brenner	2012	69
11	Evaluation of Pharmacokinetic/Pharmacodynamic Relationships of PD-0162819, a Biotin Carboxylase Inhibitor Representing a New Class of Antibacterial Compounds, Using In Vitro Infection Models Adam Ogden,Michael Kuhn,Michael Dority,Susan Buist,Shawn Mehrens,Tong Zhu,Deqing Xiao,J. Richard Miller,Debra Hanna	2011	3
12	The Use of Biochemical and Biophysical Tools for Triage of High‐Throughput Screening Hits – A Case Study with Escherichia coli Phosphopantetheine Adenylyltransferase J. Richard Miller,V. Thanabal,Michael Melnick,Manjinder S. Lall,Charles Donovan,Ronald W. Sarver,Doh‐Yeel Lee,Jeffrey F. Ohren,D.W. Emerson	2010	24
13	Discovery of novel antibacterials J. Richard Miller,Grover L. Waldrop	2010	28
14	Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim H. Heaslet,Melissa S. Harris,Kelly Fahnoe,Ronald W. Sarver,Henry Putz,Jeanne S. Chang,Chakrapani Subramanyam,Gabriela Barreiro,J. Richard Miller	2009	98
15	Structural evidence for substrate‐induced synergism and half‐sites reactivity in biotin carboxylase Igor Mochalkin,J. Richard Miller,A.G. Evdokimov,Sandra Lightle,Chunhong Yan,C. Kendall Stover,Grover L. Waldrop	2008	67
16	Streptococcus pneumononiae gyrase ATPase: Development and validation of an assay for inhibitor discovery and characterization J. Richard Miller,John T. Herberg,Mark Tomilo,Mark C. McCroskey,Bradley J. Feilmeier	2007	8
17	The Reaction of LipB, the Octanoyl-[Acyl Carrier Protein]:Protein N-Octanoyltransferase of Lipoic Acid Synthesis, Proceeds through an Acyl-Enzyme Intermediate Xin Zhao,J. Richard Miller,John E. Cronan	2005	51
18	Assembly of the Covalent Linkage between Lipoic Acid and Its Cognate Enzymes Xin Zhao,J. Richard Miller,Yanfang Jiang,Michael A. Marletta,John E. Cronan	2003	119
19	Influence of Flavin Analogue Structure on the Catalytic Activities and Flavinylation Reactions of Recombinant Human Liver Monoamine Oxidases A and B J. Richard Miller,Dale E. Edmondson	1999	29
20	Some properties of an adenosine triphosphatase obtained from beef corneal epithelium W. D. Allin,J. Richard Miller,Y. Matuk	1970	2

About J. Richard Miller

J. Richard Miller is a scholar working on Biological Psychiatry, Structural Biology and Biochemistry, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (6 papers), Metabolism and Genetic Disorders (4 papers), Cancer therapeutics and mechanisms (4 papers), Biochemical Acid Research Studies (4 papers), Amino Acid Enzymes and Metabolism (3 papers), Biotin and Related Studies (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Enzyme Structure and Function (2 papers). The work is most often cited by research in Biochemistry (323 citations), Molecular Medicine (124 citations) and Clinical Biochemistry (103 citations). J. Richard Miller has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Dale E. Edmondson, John E. Cronan, Michael A. Marletta, Xin Zhao, A.G. Evdokimov, Yanfang Jiang, Grover L. Waldrop, Gary W. Ashley, Jennifer Cheek and Brian M. Lacey.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact